Elanco Animal Health Incorporated (ELAN)
Automate Your Wheel Strategy on ELAN
With Tiblio's Option Bot, you can configure your own wheel strategy including ELAN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELAN
- Rev/Share 9.2411
- Book/Share 13.5849
- PB 1.6415
- Debt/Equity 0.5962
- CurrentRatio 2.4007
- ROIC -0.0705
- MktCap 11080055448.0
- FreeCF/Share 0.7287
- PFCF 30.6079
- PE 307.74
- Debt/Assets 0.297
- DivYield 0
- ROE 0.0055
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ELAN | Barclays | -- | Overweight | -- | $30 | Dec. 9, 2025 |
| Initiation | ELAN | KeyBanc Capital Markets | -- | Overweight | -- | $27 | Nov. 21, 2025 |
| Upgrade | ELAN | Argus | Hold | Buy | -- | $25 | Nov. 19, 2025 |
| Upgrade | ELAN | JP Morgan | Neutral | Overweight | -- | $24 | Oct. 7, 2025 |
| Upgrade | ELAN | Leerink Partners | Market Perform | Outperform | -- | $18 | July 17, 2025 |
| Upgrade | ELAN | William Blair | Market Perform | Outperform | -- | -- | June 26, 2025 |
| Initiation | ELAN | UBS | -- | Buy | -- | $18 | Dec. 9, 2024 |
| Downgrade | ELAN | Morgan Stanley | Overweight | Equal Weight | $17 | $15 | Sept. 19, 2024 |
News
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELAN.
Read More
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Published: February 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELAN.
Read More
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ELAN.
Read More
About Elanco Animal Health Incorporated (ELAN)
- IPO Date 2018-09-20
- Website https://www.elanco.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jeffrey N. Simmons
- Employees 9000